title: Strategies for reducing cancer incidence and mortality in African American and Arab American and Chaldean communities in the Detroit metropolitan area.
abstract: OBJECTIVE
  We studied the feasibility of implementing a community-based participatory process (CBPP) that addressed cancer education, prevention, and screening in 2 ethnic minority populations by evaluating the improvement in rates of cancer screening compared with historical benchmarks.
  
  
  METHODS
  From 2003 to 2009, 2281 community members participated in CBPPs conducted by the Beaumont Cancer Institute in cooperation with the Arab American and Chaldean (AAC) Council, the National Cancer Institute, and the American Cancer Society. The study population consisted of 1067 individuals who completed a postcancer forum survey: 642 from the African American (AA) and 425 from the AAC forums. Data were collected on participants' screening history and participation in subsequent screening tests after the previous year's CBPP.
  
  
  RESULTS
  Following attendance of at least one cancer forum the previous year, 329 (30.8%) of the 1067 participant respondents underwent some type of cancer screening, 32% in the AA forums and 28.9% in the AAC forums. Compared with published controls, the CBPPs led to a 38.6% increase in mammographic screening and a 28.7% increase in prostate-specific antigen screening; the AA cohort had 39.7% and 28.4% increases whereas the AAC cohort had 36.3% and 28.9% increases in mammographic and prostate-specific antigen screening, respectively.
  
  
  CONCLUSIONS
  The results of this study suggest that implementing CBPPs are feasible in underscreened ethnic minority populations. Further studies need to be performed to determine the absolute benefit of CBPPs compared with baseline levels of screening within these ethnic minority populations.
authors.affiliation: Beaumont Cancer Institute, William Beaumont Hospital, Royal Oak, MI 48072, USA. fvicini@beaumont.edu
authors.forename: Frank A
authors.initials: FA
authors.lastname: Vicini
authors.forename: Chirag
authors.initials: C
authors.lastname: Shah
authors.forename: Michelle
authors.initials: M
authors.lastname: Wallace
authors.forename: Pamela
authors.initials: P
authors.lastname: Jones
authors.forename: Vicky
authors.initials: V
authors.lastname: Dykes
authors.forename: Joyce
authors.initials: J
authors.lastname: Tull
authors.forename: Adil
authors.initials: A
authors.lastname: Akhtar
authors.forename: Samer
authors.initials: S
authors.lastname: Ballouz
authors.forename: Iqbal
authors.initials: I
authors.lastname: Boxwala
authors.forename: Vonda
authors.initials: V
authors.lastname: Douglas-Nikitin
authors.forename: Aeisha
authors.initials: A
authors.lastname: Rivers
authors.forename: Roxanne
authors.initials: R
authors.lastname: Clark
authors.forename: Ishmael
authors.initials: I
authors.lastname: Jaiyesimi
authors.forename: Monty
authors.initials: M
authors.lastname: Fakhouri
mesh_terms: D001741:Black or African American / Q000706:statistics & numerical data*; D018912:Arabs / Q000706:statistics & numerical data*; D019058:Community Networks; D005240:Feasibility Studies; D005260:Female; D006297:Health Services Accessibility; D054624:Health Status Disparities; D054625:Healthcare Disparities; D006801:Humans; D008297:Male; D008403:Mass Screening; D008824:Michigan / Q000453:epidemiology; D009369:Neoplasms / Q000453:epidemiology* / Q000401:mortality* / Q000517:prevention & control; D011315:Preventive Medicine; D011379:Prognosis